Healios Aims to Ready Stem-Cell Therapy for Eyesight By 2020 – Bloomberg
Bloomberg |
Healios Aims to Ready Stem–Cell Therapy for Eyesight By 2020
Bloomberg The Japanese company's cell-based product is intended to treat macular degeneration, the leading cause of vision loss in the elderly. If successful, it would compete with Novartis AG's Lucentis, which generated $2.4 billion in sales last year. Pfizer … |
